IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SymBiosis Capital Partners, LLC

Q4 2025 Holdings

Filed 2026-02-12 | 11 holdings | $109.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Evommune, Inc.(EVMN)COM SHS30054Y107$21.9M1,280,77820.0%
Verastem Inc(VSTM)COM NEW92337C203$15.4M2,000,00014.1%
Aldeyra Therapeutics Inc(AMPG)COM NEW03211Q200$13.2M2,555,00012.1%
Precigen Inc(PGEN)COM74017N105$12.5M3,000,00011.5%
Inventiva S.A.(IVA)ADS46124U107$12.1M2,600,00011.0%
Nuvation Bio Inc(NUVB)COM CL A67080N101$11.2M1,250,00010.2%
Rani Therapeutics Holdings, Inc.(RANI)COM CL A753018100$8.5M6,300,0007.8%
Aardvark Therapeutics, Inc.(AARD)COM002942100$6.3M476,5955.7%
Clene Nanomedicine Inc.(CLNN)COM NEW185634201$4.5M770,4954.1%
Generation Bio CoCOM NEW37148K209$3.8M665,0003.4%
Surrozen, Inc.(SRZNW)*W EXP 08/01/20386889P117$3.0K150,0000.0%